These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6133543)

  • 1. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
    Boehringer K; Weidmann P; Link L; Bianchetti MG; Schiffl H; Reubi FC
    Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.
    Bianchetti MG; Boehringer K; Weidmann P; Link L; Schiffl H; Ziegler WH
    Eur J Clin Pharmacol; 1982 Oct; 23(4):289-96. PubMed ID: 6129141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic and pharmacokinetic studies on prizidilol and nipradilol (K-351), antihypertensive drugs with combined vasodilator and beta-adrenoceptor blocking actions, in rabbits.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1984 Dec; 36(4):519-26. PubMed ID: 6151998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
    Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
    J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.
    Steiner JA; Clancy A; Manghani KK; James IM
    Br J Clin Pharmacol; 1981 Oct; 12(4):573-8. PubMed ID: 6117309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
    Andersen GS; Hartling OJ; Hein HO; Leth A
    Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
    Pitcher DW; Curry PV; Trounce JR
    Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of prizidilol and propranolol on renal haemodynamics at rest and during exercise.
    Malini PL; Strocchi E; Ambrosioni E
    Br J Clin Pharmacol; 1984 Mar; 17(3):251-5. PubMed ID: 6712858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of the stereoisomers of prizidilol: their use in analysis of reflex tachycardia and blood pressure control in normotensive cats, rats, and dogs.
    Owen DA; Eden RJ; Lamb MS; Taylor EM
    J Cardiovasc Pharmacol; 1986; 8(4):743-8. PubMed ID: 2427813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of prizidilol, a new antihypertensive drug with combined arteriolar vasodilator and beta-adrenoceptor blocking actions, with hydralazine and propranolol in conscious dogs with chronic atrioventricular block.
    Boucher M; Dubray C; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1983; 5(5):712-6. PubMed ID: 6195455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function studies with propildazine alone and in combination with propranolol in dogs.
    Dorigotti L; Semeraro C
    Eur J Pharmacol; 1980 Oct; 67(2-3):275-82. PubMed ID: 7461034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1982; 4(6):1012-7. PubMed ID: 6185765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function studies with cadralazine in conscious dogs: a comparison with hydralazine.
    Ferni G; Bonardi G; Lombroso M; Semeraro C; Dorigotti L
    Pharmacol Res; 1989; 21(2):211-22. PubMed ID: 2664751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary effects in man of oral prizidilol hydrochloride (SK&F 92657), a new antihypertensive agent.
    Edmondstone WM; Waller JF; Manghani KK; Hill PL; Bell AJ; Denison DM
    Br J Clin Pharmacol; 1983 Dec; 16(6):591-8. PubMed ID: 6140939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology and pharmacokinetics of prizidilol in hypertensive patients.
    Chaignon M; Decourt S; Guelpa G; Rocher I; Flouvat B; Guédon J
    J Cardiovasc Pharmacol; 1983; 5(6):1068-73. PubMed ID: 6196556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension.
    Pedrinelli R; Abdel-Haq B; Magagna A; Leto di Priolo S; Simonini N; Salvetti A
    Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect of prizidilol.
    Andrén L; Hansson L; Svensson A
    J Cardiovasc Pharmacol; 1983; 5(5):898-900. PubMed ID: 6195483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.